Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Commentary & Deal Flow

Related Issuers

LAUNCH/UPSIZE: Avantor 8NC3 sr notes USD1.55bn at 4.625%, EUR400m at 3.875%

HYC US Market: Deal Flow - GeneralHYC European Market: Deal Flow - General

+++Corrects Moody's rating to B3 (not B2)+++

Avantor Funding Inc (AVTR) approx USD2bn (up from USD1.452bn) 144A/Reg S sr notes 2-part. B3/B-/BB (positive/positive/stable). Via GS/Citi/Barc/JPM/BofA joint books, PNC, HSBC, Jefferies as co-managers. No reg rights.

   - USD1.550bn (up from USD1bn) due 2028 (8y). NC3 (MWC T+50bp) (par + 50% of coupon). Equity claw: 3y 40%. IPT: 5.00%-5.25%. Px talk: 4.75%-5.00%. Launched: $1.55bn at 4.625%.

   - EUR400m due 2028 (8y). NC3 (MWC B+50bp) (par +50% of coupon). Equity claw: 3y 40%. IPT 4.00%-4.25%. Px talk: 4% area. Launched: EUR400m at 3.875%.

Did investor call at 2pm UKT, 9am NYT today. Books closed at 12pm NYT/5pm UKT today. Reconfirms due at 1pm NYT/ 6pm UKT today. Pricing today NY afternoon. UOP: along with $140m cash on hand to redeem a portion (USD1.452bn) of its USD2bn 9% sr notes due 10/01/25 (MWC T+50bp). Also increasing and extending its revolver from $250m due Nov 2022 to $515m due July 2025. Biz: a global provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries, HQ: Radnor, PA.

We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.